The PTPN22 C1858T functional polymorphism and autoimmune diseases--a meta-analysis

Area of Science:

• Genetics
• Immunology
• Molecular Biology

Background:

• The protein tyrosine phosphatase non-receptor 22 (PTPN22) gene is a key regulator of immune responses.
• Polymorphisms in PTPN22, such as C1858T, have been implicated in the pathogenesis of various autoimmune diseases.
• Understanding the specific associations of PTPN22 variants with different autoimmune conditions is crucial for elucidating disease mechanisms.

Purpose of the Study:

• To conduct a meta-analysis to determine if combined evidence supports an association between the PTPN22 C1858T polymorphism and autoimmune diseases.
• To quantify the effect size of the PTPN22 C1858T polymorphism in relation to autoimmune disease susceptibility.

Main Methods:

• A comprehensive literature search was performed on Medline to identify relevant studies on the PTPN22 C1858T polymorphism and autoimmune diseases.
• Meta-analysis was conducted using random effects models for different genotype comparisons: T/T (recessive), T/T + C/T (dominant), and the T-allele.

Main Results:

• The meta-analysis included 29 studies with 43 comparisons across 10 autoimmune diseases.
• The PTPN22 1858T allele and T/T genotype showed significant associations with increased susceptibility to rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Grave's disease (GD), and type-1 diabetes (T1D).
• An association was also found with juvenile idiopathic arthritis (JIA), but not with inflammatory bowel diseases (IBD), psoriasis, multiple sclerosis, Addison's disease, or Celiac disease.

Conclusions:

• The PTPN22 1858T allele is a significant genetic risk factor conferring susceptibility to RA, SLE, GD, T1D, and JIA.
• This meta-analysis provides robust evidence for the involvement of the PTPN22 gene in the pathogenesis of a specific subset of autoimmune diseases.